Q&A: Term limits to diversify medical school leadership
Some 18% of U.S. medical school deans are women, and 12% are from other underrepresented minorities. Doctors writing in a new NEJM perspective argue setting term limits is one way to rectify these gaps. I spoke with Dr. Reshma Jagsi, a radiation oncologist at Michigan Medicine and senior author of the paper, to learn more.
Is there an ideal limit?
The NIH proposed 12-year limits for some of its leadership, but I don’t know if that’s the magic number. There are many institutions that have their own terms built in, like five-year renewable terms. Maybe you have a norm of two five-year terms, and for really good service, you allow a third five-year term. But something shy of 43 [which is one term observed in study] is probably what we want.
Could term limits have other effects?
There are other benefits: A woman may not think that a 70-kilogram white male is the anatomic norm and a smaller black woman is a deviation from the norm. [Diversity in leadership] might actually ensure that there are adequate numbers of clinical trial participants who are women and minorities.
Read the full interview here.
Is there an ideal limit?
The NIH proposed 12-year limits for some of its leadership, but I don’t know if that’s the magic number. There are many institutions that have their own terms built in, like five-year renewable terms. Maybe you have a norm of two five-year terms, and for really good service, you allow a third five-year term. But something shy of 43 [which is one term observed in study] is probably what we want.
Could term limits have other effects?
There are other benefits: A woman may not think that a 70-kilogram white male is the anatomic norm and a smaller black woman is a deviation from the norm. [Diversity in leadership] might actually ensure that there are adequate numbers of clinical trial participants who are women and minorities.
Read the full interview here.
.png)
No hay comentarios:
Publicar un comentario